Rebecca Harris

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Tim Maughan, Richard Adams, Christopher G. Smith et al. · The Lancet · 2011 · 964 citations

Gastrointestinal Oncology, Medicine, Randomised Phase 3 +8

Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab

Christopher G. Smith, David J. Fisher, Bart Claes et al. · Clinical Cancer Research · 2013 · 107 citations · Full text

<i>ASGR1</i>and<i>ASGR2</i>, the Genes that Encode the Asialoglycoprotein Receptor (Ashwell Receptor), Are Expressed in Peripheral Blood Monocytes and Show Interindividual Differences in Transcript Profile

Rebecca Harris, Carmen W. van den Berg, D. J. Bowen · Molecular Biology International · 2012 · 64 citations · Full text

Immunology, Blood Cell, Pathology +20

Exome Resequencing Identifies Potential Tumor-Suppressor Genes that Predispose to Colorectal Cancer

Christopher G. Smith, Marc Naven, Rebecca Harris et al. · Human Mutation · 2013 · 56 citations

Advanced Crc, Engineering, Cancer Pathology +23

Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy

Ayman Madi, David J. Fisher, Tim Maughan et al. · European Journal of Cancer · 2018 · 37 citations

Oncology, Oncogenic Agent, Medicine +8